BRPI0911161A2 - derivado de piridazinona - Google Patents

derivado de piridazinona

Info

Publication number: BRPI0911161A2
Authority: BR; Brazil
Prior art keywords: pyridazinone derivative; pyridazinone; derivative
Prior art date: 2008-04-21

Application number

BRPI0911161A

Other languages

English (en)

Inventor

Andree Blaukat

Dieter Dorsch

Frank Stieber

Oliver Schadt

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-21

Filing date

2009-03-24

Publication date

2015-10-06

2009-03-24 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2015-10-06 Publication of BRPI0911161A2 publication Critical patent/BRPI0911161A2/pt

2020-02-11 Publication of BRPI0911161B1 publication Critical patent/BRPI0911161B1/pt

2021-05-25 Publication of BRPI0911161B8 publication Critical patent/BRPI0911161B8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0911161A 2008-04-21 2009-03-24 derivados de piridazinona e seu processo de preparação BRPI0911161B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102008019907A DE102008019907A1 (de)	2008-04-21	2008-04-21	Pyridazinonderivate
DE102008019907.9		2008-04-21
PCT/EP2009/002137 WO2009129905A1 (de)	2008-04-21	2009-03-24	Pyridazinonderivate

Publications (3)

Publication Number	Publication Date
BRPI0911161A2 true BRPI0911161A2 (pt)	2015-10-06
BRPI0911161B1 BRPI0911161B1 (pt)	2020-02-11
BRPI0911161B8 BRPI0911161B8 (pt)	2021-05-25

Family

ID=40639931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0911161A BRPI0911161B8 (pt)	2008-04-21	2009-03-24	derivados de piridazinona e seu processo de preparação

Country Status (22)

Country	Link
US (1)	US8604036B2 (pt)
EP (1)	EP2280962B1 (pt)
JP (1)	JP5576358B2 (pt)
KR (1)	KR20100137564A (pt)
CN (1)	CN102015694A (pt)
AR (1)	AR071208A1 (pt)
AU (1)	AU2009240346B2 (pt)
BR (1)	BRPI0911161B8 (pt)
CA (1)	CA2721858C (pt)
CY (1)	CY1113443T1 (pt)
DE (1)	DE102008019907A1 (pt)
DK (1)	DK2280962T5 (pt)
EA (1)	EA018362B1 (pt)
ES (1)	ES2394147T3 (pt)
HR (1)	HRP20120884T1 (pt)
IL (1)	IL208336A (pt)
MX (1)	MX2010011454A (pt)
PL (1)	PL2280962T3 (pt)
PT (1)	PT2280962E (pt)
SI (1)	SI2280962T1 (pt)
WO (1)	WO2009129905A1 (pt)
ZA (1)	ZA201008330B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007026341A1 (de)	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
DE102007032507A1 (de)	2007-07-12	2009-04-02	Merck Patent Gmbh	Pyridazinonderivate
DE102007038957A1 (de) *	2007-08-17	2009-02-19	Merck Patent Gmbh	6-Thioxo-pyridazinderivate
DE102007061963A1 (de)	2007-12-21	2009-06-25	Merck Patent Gmbh	Pyridazinonderivate
DE102008019907A1 (de)	2008-04-21	2009-10-22	Merck Patent Gmbh	Pyridazinonderivate
DE102008028905A1 (de) *	2008-06-18	2009-12-24	Merck Patent Gmbh	3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
DE102008037790A1 (de) *	2008-08-14	2010-02-18	Merck Patent Gmbh	Bicyclische Triazolderivate
MX2011006682A (es)	2008-12-22	2011-07-13	Merck Patent Gmbh	Nuevas formas polimorficas de dihidrogeno-fosfato de 6-(1-metil-1h-pirazol-4-il)-2-{3-[5-(2-morfolin-4-il-etoxi)-pirim idin-2-il]-bencil}-2h-piridazin-3-ona y procesos para su preparacion.
CN102532126B (zh) *	2012-02-10	2014-06-18	贵州大学	2-取代-4-氯-5-[5-取代胺基-2-(1,3,4-噻二唑基)-巯基]-3(2h)-哒嗪酮类衍生物及其制备方法和用途
CA3041676A1 (en) *	2016-10-26	2018-05-03	Daniel Parks	Pyridazine derivatives, compositions and methods for modulating cftr
JP7274473B2 (ja)	2017-10-17	2023-05-16	パラウファルマ，エス．エル．ユー．	４－アミノピリミジン化合物の合成
CN108752322A (zh) *	2018-09-12	2018-11-06	广州新民培林医药科技有限公司	一种新型Tepotinib衍生物和制备方法及其在抗肿瘤药物中的应用
EA202191084A1 (ru)	2018-11-06	2021-10-19	Эджвайз Терапьютикс, Инк.	Соединения пиридазинонов и их применения
ES2957383T3 (es)	2018-11-06	2024-01-18	Edgewise Therapeutics Inc	Compuestos de piridazinona y usos de estos
JP7671245B2 (ja)	2018-11-06	2025-05-01	エッジワイズセラピューティクス，インコーポレイテッド	ピリダジノン化合物およびその使用
US11034669B2 (en)	2018-11-30	2021-06-15	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
US12435076B2 (en)	2019-11-01	2025-10-07	Unimatec Co., Ltd.	Fluorine-containing pyrimidine compound and method for producing same

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5795964A (en)	1980-12-04	1982-06-15	Morishita Seiyaku Kk	Preparation of 2-substituted-3(2h)-pyridazinone derivative
US4397854A (en)	1981-05-14	1983-08-09	Warner-Lambert Company	Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
AU691673B2 (en)	1994-11-14	1998-05-21	Dow Agrosciences Llc	Pyridazinones and their use as fungicides
US5635494A (en)	1995-04-21	1997-06-03	Rohm And Haas Company	Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
DE19604388A1 (de)	1996-02-07	1997-08-14	Merck Patent Gmbh	Arylalkyl-diazinone
BR9707495A (pt)	1996-02-13	1999-07-27	Zeneca Ltd	Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente
AU719327B2 (en)	1996-03-05	2000-05-04	Astrazeneca Ab	4-anilinoquinazoline derivatives
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
JPH10259176A (ja)	1997-03-17	1998-09-29	Japan Tobacco Inc	血管新生阻害作用を有する新規アミド誘導体及びその用途
GB9714249D0 (en)	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
MXPA00004955A (es)	1997-11-19	2002-10-17	Kowa Co	Derivados novedosos de piridazina y medicinas que los contienen como ingredientes activos.
TWI241295B (en)	1998-03-02	2005-10-11	Kowa Co	Pyridazine derivative and medicine containing the same as effect component
KR100657189B1 (ko) *	1998-08-14	2006-12-14	니혼노야쿠가부시키가이샤	피리다지논 유도체 및 이를 함유하는 의약 조성물
GB9900334D0 (en)	1999-01-07	1999-02-24	Angiogene Pharm Ltd	Tricylic vascular damaging agents
GB9900752D0 (en)	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
AUPQ462299A0 (en) *	1999-12-13	2000-01-13	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
US6242461B1 (en)	2000-01-25	2001-06-05	Pfizer Inc.	Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
IL152682A0 (en)	2000-05-31	2003-06-24	Astrazeneca Ab	Indole derivatives with vascular damaging activity
KR20030022264A (ko)	2000-07-07	2003-03-15	앤지오젠 파마슈티칼스 리미티드	신생 혈관 형성 억제제인 콜치놀 유도체
WO2002004434A1 (en)	2000-07-07	2002-01-17	Angiogene Pharmaceuticals Limited	Colchinol derivatives as vascular damaging agents
CA2462525A1 (en)	2001-10-31	2003-05-08	Merck Patent Gesellschaft Mit Beschraenkter Haftung	Type 4 phosphodiesterase inhibitors and uses thereof
CA2509565A1 (en)	2002-12-20	2004-07-15	Pharmacia Corporation	Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
JP2007516180A (ja)	2003-07-02	2007-06-21	スゲン，インコーポレイティド	ｃ−Ｍｅｔ阻害薬としてのアリールメチルトリアゾロおよびイミダゾピラジン類
US7959919B2 (en) *	2003-11-19	2011-06-14	Novelmed Therapeutics, Inc.	Method of inhibiting factor B-mediated complement activation
TW200612918A (en)	2004-07-29	2006-05-01	Threshold Pharmaceuticals Inc	Lonidamine analogs
US20070043057A1 (en)	2005-02-09	2007-02-22	Threshold Pharmaceuticals, Inc.	Lonidamine analogs
US20070015771A1 (en)	2004-07-29	2007-01-18	Threshold Pharmaceuticals, Inc.	Lonidamine analogs
WO2007044796A2 (en)	2005-10-11	2007-04-19	Nps Pharmaceuticals, Inc.	Pyridazinone compounds as calcilytics
US7728017B2 (en)	2005-11-30	2010-06-01	Vertex Pharmaceuticals Incorporated	Inhibitors of c-Met and uses thereof
DE102005057924A1 (de)	2005-12-05	2007-06-06	Merck Patent Gmbh	Pyridazinonderivate
WO2007075567A1 (en)	2005-12-21	2007-07-05	Janssen Pharmaceutica, N.V.	Triazolopyridazines as tyrosine kinase modulators
WO2007130383A2 (en)	2006-04-28	2007-11-15	Northwestern University	Compositions and treatments using pyridazine compounds and secretases
NL2000613C2 (nl)	2006-05-11	2007-11-20	Pfizer Prod Inc	Triazoolpyrazinederivaten.
GB0610680D0 (en) *	2006-05-31	2006-07-12	Istituto Di Ricerche D Biolog	Therapeutic compounds
PE20080403A1 (es)	2006-07-14	2008-04-25	Amgen Inc	Derivados heterociclicos fusionados y metodos de uso
DE102006037478A1 (de) *	2006-08-10	2008-02-14	Merck Patent Gmbh	2-(Heterocyclylbenzyl)-pyridazinonderivate
US7737149B2 (en)	2006-12-21	2010-06-15	Astrazeneca Ab	N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
MX2009008531A (es) *	2007-02-16	2009-08-26	Amgen Inc	Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
DE102007026341A1 (de)	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
DE102007032507A1 (de)	2007-07-12	2009-04-02	Merck Patent Gmbh	Pyridazinonderivate
WO2009050197A2 (en)	2007-10-16	2009-04-23	Novartis Ag	Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
CN101910158A (zh)	2007-10-25	2010-12-08	阿斯利康(瑞典)有限公司	可用于治疗细胞增殖性病症的吡啶衍生物和吡嗪衍生物
WO2009057827A1 (en)	2007-10-31	2009-05-07	Nissan Chemical Industries, Ltd.	Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
WO2009063061A2 (en)	2007-11-16	2009-05-22	Boehringer Ingelheim International Gmbh	Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US7816540B2 (en)	2007-12-21	2010-10-19	Hoffmann-La Roche Inc.	Carboxyl- or hydroxyl-substituted benzimidazole derivatives
DE102007061963A1 (de)	2007-12-21	2009-06-25	Merck Patent Gmbh	Pyridazinonderivate
PE20091339A1 (es)	2007-12-21	2009-09-26	Glaxo Group Ltd	Derivados de oxadiazol con actividad sobre receptores s1p1
CL2008003785A1 (es)	2007-12-21	2009-10-09	Du Pont	Compuestos derivados de piridazina; composiciones herbicidas que comprenden a dichos compuestos; y método para controlar el crecimiento de la vegetación indeseada.
CN101952286A (zh)	2007-12-21	2011-01-19	阿斯利康(瑞典)有限公司	用于治疗和雄激素受体有关的病症的双环衍生物
KR101610415B1 (ko)	2007-12-21	2016-04-07	에프. 호프만-라 로슈 아게	헤테로사이클릭 항바이러스 화합물
PE20091669A1 (es)	2007-12-21	2009-12-06	Exelixis Inc	Benzofuropirimidinonas
EP2072506A1 (de)	2007-12-21	2009-06-24	Bayer CropScience AG	Thiazolyloxyphenylamidine oder Thiadiazolyloxyphenylamidine und deren Verwendung als Fungizide
CL2008003799A1 (es)	2007-12-21	2009-12-18	Synthon Bv	Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
GB0725059D0 (en)	2007-12-21	2008-01-30	Syngenta Participations Ag	Novel pyridazine derivatives
SI2235012T1 (sl)	2007-12-21	2013-11-29	Palau Pharma, S.A.	4-aminopirimidinski derivati kot antagonisti histaminskega receptorja H4
US8202996B2 (en)	2007-12-21	2012-06-19	Bristol-Myers Squibb Company	Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
WO2009080533A1 (en)	2007-12-21	2009-07-02	F. Hoffmann-La Roche Ag	Heteroaryl derivatives as orexin receptor antagonists
CN101538245B (zh)	2008-03-18	2011-02-16	中国科学院上海药物研究所	一类哒嗪酮类化合物及其制备方法和制备药物的用途
DE102008019907A1 (de)	2008-04-21	2009-10-22	Merck Patent Gmbh	Pyridazinonderivate
WO2009142732A2 (en)	2008-05-20	2009-11-26	Cephalon, Inc.	Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
DE102008028905A1 (de)	2008-06-18	2009-12-24	Merck Patent Gmbh	3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
CA2729993A1 (en)	2008-07-25	2010-01-28	Boehringer Ingelheim International Gmbh	Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
WO2010113986A1 (ja)	2009-03-30	2010-10-07	住友化学株式会社	ピリダジノン化合物の有害節足動物防除用途
AR082590A1 (es)	2010-08-12	2012-12-19	Hoffmann La Roche	Inhibidores de la tirosina-quinasa de bruton

2008
- 2008-04-21 DE DE102008019907A patent/DE102008019907A1/de not_active Withdrawn
2009
- 2009-03-24 MX MX2010011454A patent/MX2010011454A/es active IP Right Grant
- 2009-03-24 AU AU2009240346A patent/AU2009240346B2/en not_active Ceased
- 2009-03-24 ES ES09734854T patent/ES2394147T3/es active Active
- 2009-03-24 US US12/988,666 patent/US8604036B2/en not_active Expired - Fee Related
- 2009-03-24 WO PCT/EP2009/002137 patent/WO2009129905A1/de not_active Ceased
- 2009-03-24 PL PL09734854T patent/PL2280962T3/pl unknown
- 2009-03-24 EP EP09734854A patent/EP2280962B1/de active Active
- 2009-03-24 CA CA2721858A patent/CA2721858C/en active Active
- 2009-03-24 CN CN2009801141150A patent/CN102015694A/zh active Pending
- 2009-03-24 PT PT97348544T patent/PT2280962E/pt unknown
- 2009-03-24 BR BRPI0911161A patent/BRPI0911161B8/pt not_active IP Right Cessation
- 2009-03-24 JP JP2011505385A patent/JP5576358B2/ja not_active Expired - Fee Related
- 2009-03-24 DK DK09734854.4T patent/DK2280962T5/da active
- 2009-03-24 EA EA201001648A patent/EA018362B1/ru not_active IP Right Cessation
- 2009-03-24 HR HRP20120884AT patent/HRP20120884T1/hr unknown
- 2009-03-24 KR KR1020107025412A patent/KR20100137564A/ko not_active Ceased
- 2009-03-24 SI SI200930411T patent/SI2280962T1/sl unknown
- 2009-04-17 AR ARP090101359A patent/AR071208A1/es not_active Application Discontinuation
2010
- 2010-09-21 IL IL208336A patent/IL208336A/en active IP Right Grant
- 2010-11-19 ZA ZA2010/08330A patent/ZA201008330B/en unknown
2012
- 2012-12-07 CY CY20121101191T patent/CY1113443T1/el unknown

Also Published As

Publication number	Publication date
JP5576358B2 (ja)	2014-08-20
CN102015694A (zh)	2011-04-13
AR071208A1 (es)	2010-06-02
BRPI0911161B1 (pt)	2020-02-11
PT2280962E (pt)	2012-12-17
DE102008019907A1 (de)	2009-10-22
CA2721858A1 (en)	2009-10-29
PL2280962T3 (pl)	2013-02-28
CA2721858C (en)	2016-07-19
HRP20120884T1 (hr)	2012-11-30
SI2280962T1 (sl)	2013-01-31
WO2009129905A1 (de)	2009-10-29
IL208336A (en)	2016-07-31
ZA201008330B (en)	2011-09-28
US8604036B2 (en)	2013-12-10
EP2280962A1 (de)	2011-02-09
KR20100137564A (ko)	2010-12-30
US20110034474A1 (en)	2011-02-10
MX2010011454A (es)	2010-12-21
DK2280962T5 (da)	2013-09-16
EP2280962B1 (de)	2012-10-03
CY1113443T1 (el)	2016-06-22
AU2009240346A1 (en)	2009-10-29
JP2011518202A (ja)	2011-06-23
EA201001648A1 (ru)	2011-06-30
AU2009240346B2 (en)	2013-10-10
BRPI0911161B8 (pt)	2021-05-25
ES2394147T3 (es)	2013-01-22
IL208336A0 (en)	2010-12-30
EA018362B1 (ru)	2013-07-30
DK2280962T3 (da)	2012-11-19

Publication	Publication Date	Title
CY2022017I2 (el)	2023-01-05	Παραγωγα πυριδαζινονης
FR24C1047I2 (fr)	2025-10-10	Derive de 4-pyrimidinesulfamide
BRPI0923497A2 (pt)	2019-09-24	derivados de piridazinona
BRPI0911161A2 (pt)	2015-10-06	derivado de piridazinona
EP2376493A4 (en)	2012-05-30	DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en)	2012-06-27	PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
BRPI0812247A2 (pt)	2015-06-16	Derivados de piridazinona
EP2226315A4 (en)	2012-01-25	2-aminoquinazoline DERIVATIVE
EP2336132A4 (en)	2012-03-21	MORPHOLINPURINDERIVAT
BRPI0821743A2 (pt)	2015-09-22	derivados de piridazinona
DK2340021T3 (da)	2012-12-10	Substituerede pyrrolidin-2-carboxamider
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
BRPI0921327A2 (pt)	2015-08-25	Combinação de herbicida-protetor
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
BRPI0913832A2 (pt)	2015-10-20	derivados de pirrolopiridinilpirimidin-2-ilamina
EP2344471A4 (en)	2012-05-30	7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
ATE545635T1 (de)	2012-03-15	Substituierte n-oxidpyrazinderivate
BRPI0913234A2 (pt)	2016-01-19	derivados de tiazolilpiperidina
BRPI0915562A2 (pt)	2016-01-26	tamis melhorado
BRPI0922652A2 (pt)	2015-08-11	Derivados de quinazolinamida
BRPI0915442A2 (pt)	2017-06-27	tamis melhorado
DK2373644T3 (da)	2012-12-10	Pyridazinonderivater
ATE534634T1 (de)	2011-12-15	2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0922728A2 (pt)	2019-09-24	combinação de herbicida-antídoto

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-03-26	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-06-04	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-09-17	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-12-24	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-02-11	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/02/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2024-01-16	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2024-05-07	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2767 DE 16-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.